Category: NASDAQAGEN
-
Agenus stock cut at Baird on FDA feedback (NASDAQ:AGEN)
•
George Clerc After falling nearly 60% in the previous session, Agenus shares (NASDAQ: Agen) Decreased by ~5% Shares of Baird fell Friday after the company downgraded its rating, citing FDA reactions to its colorectal cancer treatment combination BOT/BAL that led to selling. After meeting with Food and Drug Administration, Agnusan…